4D pharma plc Shareholders' Equity
4D pharma plc had Shareholders' Equity of $32.42 million as of 2021-12-31, per its 20-F filed 2022-03-31.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2022-03-31
- 2021-12-31: Stockholders' Equity Attributable to Parent $32.42M.
- 2021-06-30: Stockholders' Equity Attributable to Parent $39.65M; Stockholders' Equity Attributable to Parent as first filed $45.42M.
- 2020-12-31: Stockholders' Equity Attributable to Parent $38.97M.
- 2020-06-30: Stockholders' Equity Attributable to Parent $40.88M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2021-12-31 | $32.42M 20-F · filed 2022-03-31 | |
| 2021-06-30 | $39.65M 6-K/A · filed 2022-02-18 | $45.42M 6-K · filed 2021-10-01 |
| 2020-12-31 | $38.97M 20-F · filed 2022-03-31 | |
| 2020-06-30 | $40.88M 6-K/A · filed 2022-02-18 | |
| 2019-12-31 | $31.19M 20-F · filed 2022-03-31 | |
| 2018-12-31 | $60.07M 20-F · filed 2022-03-31 | |
| 2017-12-31 | $96.30M 20-F/A · filed 2021-04-30 |